Get the Daily Brief
Latest Biotech News
Lilly Selects Virginia for $5B API Bioconjugate Manufacturing Facility
Eli Lilly has chosen West Creek Business Park near Richmond, Virginia, to build a $5 billion manufacturing plant dedicated to producing active pharmaceutical ingredients (APIs) for monoclonal...
US Pharma Investment Retreats From UK Amid Regulatory and Pricing Uncertainty
Major pharmaceutical companies including AstraZeneca, Merck, and Eli Lilly have withheld or halted planned investments totaling hundreds of millions of dollars in the UK life sciences sector....
New CRISPR-Based Oral Swab Test Enhances Tuberculosis Detection
Researchers at Tulane University have developed ActCRISPR-TB, a novel CRISPR-Cas12a assay enabling rapid, sensitive detection of Mycobacterium tuberculosis DNA from a simple tongue swab. This...
AI and Deep Learning Platforms Accelerate Drug Discovery and Precision Oncology
Artificial intelligence is increasingly embedded in biopharma, with innovative AI platforms transforming drug discovery and precision medicine. Stanford Medicine unveiled CRISPR-GPT, an AI...
Lila Sciences Raises $235 Million for AI-Powered Autonomous Research Labs
Lila Sciences, a startup developing AI-driven autonomous research labs to accelerate scientific discovery, has secured $235 million in Series A funding. The company aims to create 'scientific...
Mount Sinai Opens AI Research Lab for Cardiac Catheterization Advances
Mount Sinai Fuster Heart Hospital has launched The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab, integrating cutting-edge AI algorithms with cardiology expertise to...
Breakthroughs in Alzheimer’s Disease: New Blood Tests and Therapeutics
Recent advances in Alzheimer’s research highlight new diagnostic and therapeutic frontiers. Novel blood tests improve early detection of amyloid and tau pathologies, facilitating timely diagnosis...
Novartis Expands Protein Degrader Collaboration with Monte Rosa – $5.7 Billion Deal
Novartis and Monte Rosa Therapeutics have entered an expanded research collaboration worth up to $5.7 billion, advancing molecular glue degraders for immune-mediated diseases. This new agreement...
Pharma Firms Freeze UK R&D Amid Drug Pricing Turmoil – AstraZeneca, Sanofi, Merck Pull Back
AstraZeneca paused its $271 million Cambridge expansion, completing a withdrawal from its $884 million UK investment package amid frustrations with government support and pricing policies. Sanofi...
Atyr Pharma's Efzofitimod Fails Phase 3 Pulmonary Sarcoidosis Trial – Shares Plunge
Atyr Pharma reported that efzofitimod did not achieve its primary endpoint of steroid dose reduction in a Phase 3 trial involving pulmonary sarcoidosis patients. While some secondary outcomes...
Lila Sciences Raises $235 Million to Build AI-Powered Autonomous Research Labs
Flagship Pioneering-backed Lila Sciences secured a $235 million Series A funding round to develop fully autonomous labs integrating artificial intelligence into biological research workflows....
Eli Lilly Selects Virginia for $5 Billion API Manufacturing Site with ADC Focus
Eli Lilly announced the selection of Goochland County, Virginia, as the site for a new $5 billion active pharmaceutical ingredient (API) manufacturing facility, the first dedicated fully...
Breakthrough AI Algorithm Uses Mammograms to Predict Cardiovascular Risk in Women
The George Institute for Global Health researchers developed a machine learning model that analyzes routine mammographic images to accurately predict women's cardiovascular disease risk. This...
FDA Cracks Down on Pharma Ads – Letters Target Misleading Drug Promotions
The FDA released approximately 100 warning letters to pharmaceutical companies and telehealth providers, including Novartis and Eli Lilly, demanding changes to drug advertisements deemed...
Personalized Ovarian Cancer Risk Score Unveiled – Queen Mary University Advances Early Detection
Researchers at Queen Mary University of London introduced Ovatools, a personalized diagnostic instrument combining biochemical markers with demographic data for improved ovarian cancer risk...
Human Proteoform Atlas Aims to Advance Precision Medicine – Mapping Protein Variants
A collaborative effort seeks to comprehensively map the myriad proteoforms—the distinct molecular forms of proteins produced from a single gene—across human tissues. This project aims to establish...
Advanced Biomanufacturing: CDMO Market Expands Amid Rising Biologic Demand
A Jefferies report highlights robust growth in contract development and manufacturing organizations (CDMOs), fuelled primarily by rising demand for biologics including monoclonal antibodies and...
Lilly Picks Virginia for $5 Billion Bioconjugate Manufacturing Hub
Eli Lilly has selected a site near Richmond, Virginia, for its first fully integrated active pharmaceutical ingredient (API) and drug product facility dedicated to bioconjugates including...
Novartis Expands Collaboration with Monte Rosa in Molecular Glue Drug Development
Novartis has entered a new partnership with Monte Rosa Therapeutics, securing an exclusive license to a novel molecular glue degrader drug candidate and options on two additional preclinical...
FDA Approves Biocartis Colorectal Cancer Companion Diagnostic Test
Biocartis has achieved FDA premarket approval for its Idylla Cdx MSI Test, designed to identify colorectal cancer patients with microsatellite instability-high (MSI-H) tumors who may benefit from...